Pfizer buys 5 percent stake in Medarex BOSTON (CBS.MW) - Pharmaceutical powerhouse Pfizer is buying a 5 percent stake in biotechnology researcher Medarex under their newly signed collaboration deal, according to Medarex Chief Executive Donald Drakeman. 
Is this a piece of news regarding world politics, sports, business, or science and technology? 